SR One Capital Management — 2016 Investments
5 investments dated 2016 · listed companies and verified rows first · show all
Progyny provides employer-sponsored women's health and family-building benefits, covering preconception, fertility, pregnancy and postpartum, and menopause/midlife care through concierge support, digital tools, and a managed network of specialists.
Digital HealthFemTechHealthtechHR Tech
Gina Bartasi(Founder)inPeter Anevski(Chief Executive Officer and Director)
Co-investorsAurumKleiner PerkinsM VenturesSavano Capital PartnersUnion Grove Venture Partners
CRISPR Therapeutics is a biotechnology company developing gene-based medicines using CRISPR/Cas9 gene-editing technology.
BiotechDeep TechHealthtechZug, CH
Emmanuelle Charpentier(Founder)Samarth Kulkarni(Chief Executive Officer and Chairman of the Board)inJames R. Kasinger(General Counsel and Secretary)inStephen Kennedy(Head of Technical Operations)inMegan Wherry Menner(Head of Human Resources)inNaimish Patel(Chief Medical Officer)in
Board seatSimeon J. George· per SEC Form D
Co-investorsAvoro Capital AdvisorsCLI VenturesKhosla VenturesNew Enterprise Associates (NEA)Versant VenturesWellington Management+2 more
Co-investorsAvego BioScience CapitalBioGenerator VenturesPerot JainRiverVest Venture PartnersRoche Venture Fund
Co-investorsLifeforce CapitalPfizer Venture InvestmentsDigitalis VenturesLightstone VenturesMorgenthalerRoche Venture Fund
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.














